HKSTP to Promote Hong Kong’s Vibrant Biotechnology and Fintech Ecosystems at Think Asia Think Hong Kong in Los Angeles

September 17, 2019 |

5 min read

Homegrown partner companies and startups to share their latest innovations on advanced therapeutics, precision medicine, diagnostics, genetics and ICT solutions

Sept. 17, 2019 13:53 UTC

Homegrown partner companies and startups to share their latest innovations on advanced therapeutics, precision medicine, diagnostics, genetics and ICT solutions

HONG KONG--(BUSINESS WIRE)-- Hong Kong Science and Technology Parks Corporation (HKSTP) will take part in the annual Think Asia Think Hong Kong event (TATHK), to be held on 20 September 2019 in Los Angeles, USA. TATHK is an international event organised by the Hong Kong Trade Development Council (HKTDC) to highlight Hong Kong’s pivotal role in connecting Asia’s vibrant and expanding markets to the rest of the world.

Hong Kong’s innovation and technology (I&T) sector has been gaining ground as a crucial pillar of Hong Kong’s economy, and has been a major focus area promoted at TATHK events in recent years. For this year’s event, the biotech sector will receive extra focus to attract talent and investments to Hong Kong. HKSTP will host a thematic session “Riding the Wave of Health Innovations – Invest in Hong Kong Biotech” at TATHK, where Prof. John Kao, Head of the Biomedical Cluster of HKSTP will share the latest developments, insights and investment landscape in Hong Kong’s biotechnology and healthcare industries. Meanwhile, thriving partner companies and incubatees will focus on their success stories in commercialising their research outputs, and share their experience in being part of Hong Kong’s vibrant I&T ecosystem.

Albert Wong, CEO of HKSTP will take part in another thematic session hosted by the Hong Kong Monetary Authority, “Smart Banking empowering rapid fintech development in Hong Kong.” He will share the current fintech landscape and related R&D in Hong Kong, as well as case studies that HKSTP has supported.

In addition to the thematic sessions, five of HKSTP’s biotech partner companies and incubatees, including Arbele, Codex Genetics, Opharmic Technology (HK), RainsOptics and Sanomics will showcase their innovations at the InnoVenture Salon of TATHK and explore potential partnership and investment opportunities with other global entrepreneurs and the U.S. business community. HKSTP will also reach out to the US startups and talent by introducing the various mentoring, acceleration and incubation programmes offered by HKSTP, as well as sharing Hong Kong’s unique advantages as a platform to expand into China and the Asian market.

In addition, as a continued effort to promote Hong Kong’s emerging ICT and fintech start-ups, another 11 park companies will be included into the delegation for HKTDC’s “Hong Kong Tech & Startup” mission, happening in the same week in San Diego from 17 – 20 September. These companies will also showcase their emerging tech solutions at the InnoVenture Salon.

HKSTP Thematic Session: “Riding the Wave of Health Innovations – Invest in Hong Kong Biotech”

Date:	20 September 2019 (Friday)
Venue:	Platinum Ballroom Salon F, 2/F, JW Marriott Los Angeles LA LIVE
Time:	1:45pm	Registration
	2:00pm	Opening Remarks Prof John Kao, Head of Biomedical Technology Cluster, Hong Kong Science and Technology Parks Corporation
	2:10pm	From Bench to Bedside - Transforming Hong Kong Applied Research into Medical Products Dr Langston Suen, Chief Executive Officer, Opharmic Technology (HK) Limited
	2:20pm	A Hong Kong’s Innovation for Prevention of Blindness - Retinal Imaging for Anyone Dr Kenny Lai, Chief Executive Officer, RainsOptics Limited
	2:30pm	Precision Cancer Medicines: from HK to Greater Bay Area and Beyond Prof John Luk, Chief Executive Officer, Arbele Limited
	2:40pm	The Edge of HK Start-Up in Biotechnology Dr Stanley Sy, Chief Executive Officer, Sanomics Limited
	2:50pm	Stories Behind the Numbers - Managing Rare Diseases in Hong Kong Mr Aldrin Yim, Chief Executive Officer, Codex Genetics Limited
	3:00pm	From BioTech to Regional Business Mr Jimmy Tao, Chief Executive Officer & Managing Director, Vitargent (International) Biotechnology Limited
	3:10pm	Panel Discussion Panel Chair: Prof John Kao Panel Speakers: Dr Langston Suen Dr Kenny Lai Prof John Luk Dr Stanley Sy Mr Aldrin Yim Mr Jimmy Tao
	3:55pm	Networking Session

For more details and registration, please visit the TATHK website: (www.thinkasiathinkhk.com/2019).

About Hong Kong Science and Technology Parks Corporation

Comprising Science Park, InnoCentre and Industrial Estates, Hong Kong Science & Technology Parks Corporation (HKSTP) is a statutory body dedicated to building a vibrant innovation and technology ecosystem to connect stakeholders, nurture technology talents, facilitate collaboration, and catalyse innovations to deliver social and economic benefits to Hong Kong and the region.

Established in May 2001, HKSTP has been driving the development of Hong Kong into a regional hub for innovation and growth in several focused clusters including Electronics, Information & Communications Technology, Green Technology, Biomedical Technology, Materials and Precision Engineering. We enable science and technology companies to nurture ideas, innovate and grow, supported by our R&D facilities, infrastructure, and market-led laboratories and technical centres with professional support services. We also offer value added services and comprehensive incubation programmes for technology start-ups to accelerate their growth.

Technology businesses benefit from our specialised services and infrastructure at Science Park for applied research and product development; enterprises can find creative design support at InnoCentre; while skill-intensive businesses are served by our three industrial estates at Tai Po, Tseung Kwan O and Yuen Long. More information about HKSTP is available at www.hkstp.org.